Ligand · 501
501 · N7-butyl-N2-(5-chloro-2-methylphenyl)-5-methyl[1,2,4]triazolo[1,5-a]pyrimidine-2,7-diamine
501, N7-butyl-N2-(5-chloro-2-methylphenyl)-5-methyl[1,2,4]triazolo[1,5-a]pyrimidine-2,7-diamine (C17 H21 Cl N6, 344.8 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues…
- Component
- 501
- Formula
- C17 H21 Cl N6
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
501 in 2 structures; the first of them:
- 1ZGV · Thrombin in complex with an oxazolopyridine inhibitor 2 · 501 A1001 · binds HIS57, TYR60A, TRP60D, GLU97A, ASN98, LEU99, ILE174, ASP189 and 13 more
- 1ZGV · Thrombin in complex with an oxazolopyridine inhibitor 2 · 501 A1001 · binds HIS57, TYR60A, TRP60D, GLU97A, ASN98, LEU99, ILE174, ASP189 and 13 more
Residues it binds most
GLY 2, CYS 2, GLU 2, SER 2, TRP 2, TYR 2, ALA 2, ASN 2, ASP 2, HIS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.